Torthaí cuardaigh - Antonio D’Alessio
- 1 - 20 toradh as 24 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials de réir Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Chiara Airoldi, Lorenza Scotti, Coşkun Özer Demirtas, Alessandra Gennari, Alessio Cortellini, David J. Pinato
Foilsithe / Cruthaithe 2022Revisão -
3
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma de réir Ambreen Muhammed, Antonio D’Alessio, Andrei Enica, Thomas Talbot, Claudia Angela Maria Fulgenzi, Georgios Nteliopoulos, Robert Goldin, Alessio Cortellini, David J. Pinato
Foilsithe / Cruthaithe 2022Revisão -
4
Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials de réir Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Charalampos‐Vlasios Stikas, Alessandra Gennari, Bruno Vincenzi, Mark R. Openshaw, Marianna Silletta, Matthias Pinter, Alessio Cortellini, Lorenza Scotti, Antonio D’Alessio, David J. Pinato
Foilsithe / Cruthaithe 2023Artigo -
5
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma de réir David J. Pinato, Xiaoxue Li, Pallavi S. Mishra‐Kalyani, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Matthias Pinter, Guo Wei, Julie A. Schneider, Donna R. Rivera, Richard Pazdur, Marc R. Theoret, Sandra J. Casak, Steven J. Lemery, Lola A. Fashoyin‐Aje, Alessio Cortellini, Lorraine Pelosof
Foilsithe / Cruthaithe 2023Artigo -
6
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis de réir Antonio D’Alessio, Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Vincent Yip, Sarah Slater, Claudia Angela Maria Fulgenzi, Ciro Celsa, Giulia Francesca Manfredi, Madhava Pai, Robert Goldin, Stephen C. Ward, Maria Isabel Fiel, Daniel Shu, Yung‐Yeh Su, Alessio Cortellini, Marina Baretti, Robert Anders, Mark Yarchoan, Chiun Hsu, Thomas U. Marron, David J. Pinato
Foilsithe / Cruthaithe 2024Artigo -
7
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched s... de réir Brett Marinelli, Edward Kim, Antonio D’Alessio, Mario A. Cedillo, Ishan Sinha, Neha Debnath, Masatoshi Kudo, Naoshi Nishida, Anwaar Saeed, Hannah Hildebrand, Ahmed O. Kaseb, Yehia I. Abugabal, Anjana Pillai, Yi‐Hsiang Huang, Uqba Khan, Mahvish Muzaffar, Abdul Rafeh Naqash, Rahul Patel, A. Fischman, V. Bishay, Dominik Bettinger, Max W. Sung, Celina Ang, Myron Schwartz, David J. Pinato, Thomas U. Marron
Foilsithe / Cruthaithe 2022Artigo -
8
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study de réir David J. Pinato, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesús Miguéns Blanco, Caroline Ward, Charalampos‐Vlasios Stikas, Mark R. Openshaw, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C. Keun, Robert Goldin, Paul J. Ross, Alessio Cortellini, Robert Thomas, Anna-Mary Young, Nathan Danckert, Paul Tait, Julian R. Marchesi, Bertram Bengsch, Rohini Sharma
Foilsithe / Cruthaithe 2024Artigo -
9
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma de réir Enrui Xie, Yee Hui Yeo, Bernhard Scheiner, Yue Zhang, Atsushi Hiraoka, Xinxing Tantai, Petros Fessas, Tiago B. R. Castro, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Shuo Xu, Hong‐Ming Tsai, Swetha Kambhampati, Wenjun Wang, Bridget P. Keenan, Xu Gao, Zixuan Xing, Matthias Pinter, Yih‐Jyh Lin, Zhanjun Guo, Arndt Vogel, T. Tanaka, Hsin‐Yu Kuo, Robin Kate Kelley, Masatoshi Kudo, Ju Dong Yang, David J. Pinato, Fanpu Ji
Foilsithe / Cruthaithe 2023Artigo -
10
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations de réir Alessio Cortellini, Biagio Ricciuti, Victor R. Vaz, Davide Soldato, Joao V. Alessi, Filippo Gustavo Dall’Olio, Giuseppe Luigi Banna, S. Muthuramalingam, Samuel Chan, Margarita Majem, A. Piedra, Giuseppe Lamberti, Elisa Andrini, Alfredo Addeo, Alex Friedlaender, Francesco Facchinetti, Teresa Gorría, Laura Mezquita, Delphine Hoton, Lacroix Valerie, Frank Aboubakar Nana, James Artingstall, Charles Comins, Massimo Di Maïo, Andrea Caglio, Judith Cave, Hayley McKenzie, Thomas Newsom-Davis, Joanne Evans, Marcello Tiseo, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Benjamin Besse, Mark M. Awad, David J. Pinato
Foilsithe / Cruthaithe 2022Artigo -
11
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study de réir Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Vincent E. Gaillard, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Rohini Sharma, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato
Foilsithe / Cruthaithe 2022Artigo -
12
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma de réir Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma
Foilsithe / Cruthaithe 2022Artigo -
13
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab de réir Linda Y. Wu, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi‐Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Rohini Sharma, Alessio Cortellini, Vincent E. Gaillard, Hong Jae Chon, David J. Pinato, Celina Ang
Foilsithe / Cruthaithe 2022Artigo -
14
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study de réir Thomas Talbot, Antonio D’Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia Angela Maria Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei‐Chang Lee, Yi‐Hsiang Huang, Bertram Bengsch, Dominik Bettinger, Yehia I. Mohamed, Ahmed O. Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter R. Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David J. Pinato
Foilsithe / Cruthaithe 2022Artigo -
15
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma de réir Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma
Foilsithe / Cruthaithe 2023Artigo -
16
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study de réir Claudia Angela Maria Fulgenzi, Jaekyung Cheon, Antonio D’Alessio, Naoshi Nishida, Celina Ang, Thomas U. Marron, Linda Y. Wu, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Andrea Napolitano, Yi‐Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Rohini Sharma, Alessio Cortellini, Vincent E. Gaillard, Hong Jae Chon, David J. Pinato
Foilsithe / Cruthaithe 2022Artigo -
17
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma de réir Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Musharraf Navaid, Abdul Rafeh Naqash, Anuhya Gampa, Umut Özbek, Junk-Yi Lin, Ylenia Perone, Bruno Vincenzi, Marianna Silletta, Anjana Pillai, Yinghong Wang, Uqba Khan, Yi‐Hsiang Huang, Dominik Bettinger, Yehia I. Abugabal, Ahmed O. Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Luca Di Tommaso, Masatoshi Kudo, Arndt Vogel, Francesco Mauri, Alessio Cortellini, Rohini Sharma, Antonio D’Alessio, Celina Ang, David J. Pinato
Foilsithe / Cruthaithe 2021Artigo -
18
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma de réir Bernhard Scheiner, Daniel Roessler, Samuel Phen, Mir Lim, Katharina Pomej, Tiziana Pressiani, Antonella Cammarota, Thorben Fründt, Johann von Felden, Kornelius Schulze, Vera Himmelsbach, Fabian Finkelmeier, Ansgar Deibel, Alexander Siebenhüner, Kateryna Shmanko, Pompilia Radu, Birgit Schwacha-Eipper, Matthias P. Ebert, Andreas Teufel, Angela Djanani, Florian Hucke, Lorenz Balcar, Alexander Philipp, David Hsiehchen, Marino Venerito, Friedrich Sinner, Michael Trauner, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, David J. Pinato, Markus Peck‐Radosavljevic, Jean‐François Dufour, Arndt Weinmann, Andreas E. Kremer, Amit G. Singal, Enrico N. De Toni, Lorenza Rimassa, Matthias Pinter
Foilsithe / Cruthaithe 2022Artigo -
19
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer de réir Alessio Cortellini, Antonio D’Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Paola Bordi, Giuseppe Tonini, Bruno Vincenzi, Marco Tucci, Alessandro Russo, Francesco Pantano, Marco Russano, Luigia Stefania Stucci, Maria Chiara Sergi, Martina Falconi, Maria Antonietta Zarzana, Daniele Santini, Francesco Spagnolo, Enrica T. Tanda, Francesca Rastelli, Francesca Chiara Giorgi, Federica Pergolesi, Raffaele Giusti, Marco Filetti, Francesca Lo Bianco, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Paola Queirolo, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Chiara Spoto, Maria Grazia Vitale, Katia Cannita, Alessandra Gennari, Daniel L. Morganstein, Domenico Mallardo, Lorenzo Nibid, Giovanna Sabarese, Leonardo Brunetti, Giuseppe Perrone, Paolo A. Ascierto, Corrado Ficorella, David J. Pinato
Foilsithe / Cruthaithe 2023Artigo -
20
Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study de réir Sergio Muñoz, Víctor Sapena, Alejandro Forner, Jordi Bruix, Marco Sanduzzi‐Zamparelli, José Ríos, Mohamed Bouattour, Mohamed El‐Kassas, Cássia Regina Guedes Leal, Tudor Mocan, Jean‐Charles Nault, Rogério Camargo Pinheiro Alves, Helen L. Reeves, Leonardo Gomes da Fonseca, Ignacio García‐Juárez, David J. Pinato, Marı́a Varela, Saleh A. Alqahtani, Mário Reis Álvares‐da‐Silva, Juan Carlos Bandi, Lorenza Rimassa, Mar Lozano, Jesús M. González‐Santiago, Frank Tacke, María Sala, Margarita Anders, Anja Lachenmayer, Federico Piñero, Alex Vianey Callado França, Maria Guarino, Alessandra Elvevi, Giuseppe Cabibbo, Markus Peck‐Radosavljevic, Ángela Rojas, Mercedes Vergara, Chiara Braconi, Sonia Pascual, Christie Perelló, Vivianne Mello, Carlos Rodríguez de Lope, Juan Acevedo, Rosanna Villani, Clémence Hollande, Valérie Vilgrain, Ahmed Tawheed, Carmem Theodoro, Zeno Spârchez, Lorraine Blaise, Daniele E. Viera‐Alves, Robyn Watson, Flair José Carrilho, Carlos Moctezuma‐Velázquez, Antonio D’Alessio, Massimo Iavarone, María Reig
Foilsithe / Cruthaithe 2022Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Hepatocellular carcinoma
Oncology
Cancer
Immunotherapy
Gastroenterology
Chemotherapy
Adverse effect
Atezolizumab
Bevacizumab
Nivolumab
Confidence interval
Biology
Hazard ratio
Cohort
Sorafenib
Cirrhosis
Immune checkpoint
Lenvatinib
Liver cancer
Paleontology
Biochemistry
Cancer research
Clinical trial
Context (archaeology)
Disease
Immunology
Overall survival
Pembrolizumab